Li, N.
van Oostwaard, M.
van den Bergh, J. P.
Hiligsmann, M.
Boonen, A.
van Kuijk, S. M. J.
Vranken, L.
Bours, S. P. G.
Wyers, C. E.
Article History
Received: 28 June 2021
Accepted: 8 October 2021
First Online: 20 October 2021
Declarations
:
: Joop P. van den Bergh has received research funding from Amgen, and UCB; Mickaƫl Hiligsmann has received research grants through institution from Amgen, Radius Health, and ViiV, consulting fee from UCB, and lecture fee from Mylan Pharmaceuticals; Annelies Boonen, Sandrine P.G. Bours, Caroline E. Wyers, Sander MJ van Kuijk, Lisanne Vranken, and Marsha M. van Oostwaard declare that they have no conflict of interest.